BamSEC and AlphaSense Join Forces
Learn More

Evoke Pharma Inc.

NASDAQ: EVOK    
Share price (1/6/25): $4.60    
Market cap (1/6/25): $6.836 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 10-Q 4 pages Seventh Amendment to Lease
12/34/56
EX-10.3
from 10-Q 16 pages Amended and Restated Employment Agreement
12/34/56
EX-10.2
from 10-Q 16 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 10-Q 16 pages Second Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 4 pages Evoke Pharma, Inc. 420 Stevens Avenue, Suite 230 Solana Beach, Ca 92075 Re: Warrant Amendments, Dated September 27, 2024, to Those Certain Series a Common Stock Purchase Warrants and Series C Common Stock Purchase Warrants
12/34/56
EX-10.1
from 8-K 2 pages Material contract
12/34/56
EX-10.11
from 10-K/A 57 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because Evoke Pharma, Inc. Has Determined the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm to Evoke Pharma, Inc. if Publicly Disclosed. Manufacturing Services Agreement 7 November 2017
12/34/56
EX-10.11
from 10-K 57 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because Evoke Pharma, Inc. Has Determined the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm to Evoke Pharma, Inc. if Publicly Disclosed. Manufacturing Services Agreement 7 November 2017
12/34/56
EX-10.1
from 10-Q 8 pages Sixth Amendment to Lease This Sixth Amendment to Lease (This “Amendment”) Is Made, for Reference Purposes Only, October 9, 2023 , by and Between Sb Corporate Centre III-IV, LLC, a Delaware Limited Liability Company (“Landlord”), and Evoke Pharma, Inc., a Delaware Corporation (“Tenant”), With Reference to the Following Facts
12/34/56
EX-10.1
from 10-Q 5 pages Evoke Pharma, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 5 pages Evoke Pharma, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 8-K 13 pages Evoke Pharma, Inc. 2013 Employee Stock Purchase Plan (As Amended and Restated Effective May 10, 2023) Article 1. Purpose
12/34/56
EX-10.1
from 8-K 33 pages Evoke Pharma, Inc. 2013 Equity Incentive Award Plan (As Amended and Restated Effective May 10, 2023) Article 1. Purpose
12/34/56
EX-10
from 10-K 4 pages Fifth Amendment to Lease
12/34/56
EX-10.1
from 10-Q 4 pages Amendment No. 2 to the Commercial Services Agreement
12/34/56
EX-10..1
from 10-Q 3 pages Amendment No. 1 to the Commercial Services Agreement
12/34/56
EX-10.34
from 10-K 3 pages Fourth Amendment to Lease
12/34/56
EX-10.33
from 10-K 4 pages Evoke Pharma, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.32
from 10-K 4 pages Evoke Pharma, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.30
from 10-K 3 pages Third Amendment to Lease
12/34/56